"Andrew Hill, a researcher in the Department of Pharmacology and Therapeutics at the University of Liverpool, says $84,000 per cure is too much, based on his estimate of Gilead's cost to produce the drug.
"Even when we were very conservative [with our estimate], the cost of a course of these treatments would be on the order of $150 to $250 per person," Hill says. He questions whether the $84,000 price tag represents "a fair profit."
Hill estimated the cost of producing sofosbuvir by comparing it to similar antiviral drugs used to treat HIV, which cost about a $1 per gram to make."
Please read more at:
http://www.npr.org/blogs/health/2013/12 ... =17&f=1001